We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TSNDF market cap is 294.65M. The company's latest EPS is USD -0.2691 and P/E is -4.27.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 90.35M | 147.83M | 210.42M | 250.51M | 317.33M |
Operating Income | -134.94M | 20.5M | 31.93M | -349.7M | -14.21M |
Net Income | -215.79M | -139.2M | 3.11M | -329.91M | -95.55M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 460.77M | 427.24M | 581.93M | 701.59M | 666.52M |
Total Liabilities | 385.44M | 440.56M | 352.98M | 380.42M | 425.78M |
Total Equity | 75.33M | -13.32M | 228.95M | 321.17M | 240.74M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -47.91M | -36.97M | -31.82M | -26.12M | 27.47M |
Investing | -138.22M | -45.89M | -132.42M | -27.58M | -16.22M |
Financing | 176.98M | 133.41M | 182.2M | 3.72M | -12.5M |
Market Cap | 294.65M |
Price to Earnings Ratio | -4.27 |
Price to Sales Ratio | 1.29 |
Price to Cash Ratio | 18.34 |
Price to Book Ratio | 1.7 |
Dividend Yield | - |
Shares Outstanding | 355M |
Average Volume (1 week) | 418.16k |
Average Volume (1 Month) | 441.23k |
52 Week Change | -47.80% |
52 Week High | 2.45 |
52 Week Low | 0.66 |
Spread (Intraday) | 0.08 (9.31%) |
Company Name | Terrascend Corporation (QX) |
Address |
3610 mavis road mississauga, ontario L5C 1W2 |
Website | https://www.terrascend.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions